Big Pharma CEO defends COVID profit motive | Humana + Heal for housecalls | Surviving supply shortages

The head of the largest pharmaceutical company by revenues is pulling no punches defending the profit motive in the fight against COVID-19.

Humana is sinking $100 million into a primary care startup to send doctors into patients’ homes via 1-touch telemed or old-school housecalls.

Before COVID hit, the U.S. was importing around a third of its PPE from China. Then that most populous of all countries moved to protect its own people, keeping what it used to ship.

The honor roll, which recognizes 20 hospitals that excel in numerous care concentrations, is only part of a “Best Hospitals” package the publication has retooled for this, the year of the pandemic. 

The largest health system in the smallest state has agreed to pay $1,040,000 to HHS’s Office for Civil Rights (OCR).

Contrary to popular politicized opinion, hydroxychloroquine can be highly effective against COVID-19, according to a seasoned epidemiology professor at the Yale School of Public Health.

Researchers have demonstrated the use of an AI tool that can accurately identify or rule out prostate cancer on digitized pathology slides from core needle biopsies.

Hydroxychloroquine was once just an ordinary antimalarial medication—and then 2020 and COVID-19 happened. So how did we get here? 

Researchers tracked data related to more than 178 million U.S. residents. Their findings could help with the development of public policies going forward.